75 related articles for article (PubMed ID: 2375076)
21. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
[TBL] [Abstract][Full Text] [Related]
22. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
23. Seasonal variations in serum sodium levels and other biochemical parameters among peritoneal dialysis patients.
Li SY; Chen JY; Chuang CL; Chen TW
Nephrol Dial Transplant; 2008 Feb; 23(2):687-92. PubMed ID: 17890245
[TBL] [Abstract][Full Text] [Related]
24. Calcium exposure and removal in chronic hemodialysis patients.
Sigrist M; McIntyre CW
J Ren Nutr; 2006 Jan; 16(1):41-6. PubMed ID: 16414440
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
[TBL] [Abstract][Full Text] [Related]
26. The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis.
Po CL; Afolabi M; Raja RM
ASAIO J; 1993; 39(3):M798-800. PubMed ID: 8268648
[TBL] [Abstract][Full Text] [Related]
27. Fluid-shift during computer-modulated profile hemodialysis (CMP-HD).
Keuchel M; Dittmar A; Saure B; Laage C; Ebel H; Lange H
Int J Artif Organs; 1991 Oct; 14(10):630-3. PubMed ID: 1748530
[TBL] [Abstract][Full Text] [Related]
28. The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients.
Moret K; Aalten J; van den Wall Bake W; Gerlag P; Beerenhout C; van der Sande F; Leunissen K; Kooman J
Nephrol Dial Transplant; 2006 Jan; 21(1):138-44. PubMed ID: 16144849
[TBL] [Abstract][Full Text] [Related]
29. Long-term haemodialysis treatment with sodium removal by convection.
Locatelli F; Pedrini L; Ponti R; Costanzo R; Di Filippo S; Marai P; Pozzi C; Bonacina GP
Proc Eur Dial Transplant Assoc; 1981; 18():146-52. PubMed ID: 7329962
[TBL] [Abstract][Full Text] [Related]
30. [Determination of urea distribution space on the basis of hemodialysis quantification].
Erben J; Schück O; Moucka P; Fixa P; Hájková B; Herout V; Stilec R; Zahradník J; Palicka V
Vnitr Lek; 1993 Dec; 39(12):1148, 1151-6. PubMed ID: 8310663
[TBL] [Abstract][Full Text] [Related]
31. [Bicarbonate hemodialysis in the therapy of chronic kidney failure].
Riabov SI; Shostka GD; Spiridonov VN; Vasil'ev AN; Kozlov VV
Ter Arkh; 1988; 60(5):76-80. PubMed ID: 3175934
[TBL] [Abstract][Full Text] [Related]
32. Hemofiltration for long-term maintenance of patients with end stage renal disease: impact on hypertension.
Henderson LW; Sanfelippo ML; Stone RA
Adv Nephrol Necker Hosp; 1980; 9():21-32. PubMed ID: 6773312
[No Abstract] [Full Text] [Related]
33. A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease.
Wendland EM; Kaplan AA
Semin Dial; 2012; 25(1):82-5. PubMed ID: 21906168
[TBL] [Abstract][Full Text] [Related]
34. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
35. Body fluid composition in chronic renal failure.
Bauer JH; Brooks CS
Clin Nephrol; 1981 Sep; 16(3):114-8. PubMed ID: 7296968
[TBL] [Abstract][Full Text] [Related]
36. Serum beta 2 microglobulin and extracellular fluid volume during haemodialysis.
Chanard J; Toupance O; Lavaud S; Jaisser F; Gillery P
Nephrol Dial Transplant; 1989; 4(6):549-54. PubMed ID: 2507977
[TBL] [Abstract][Full Text] [Related]
37. Importance of volume factors in dialysis related hypertension.
Lins RL; Elseviers M; Rogiers P; Van Hoeyweghen RJ; De Raedt H; Zachee P; Daelemans RA
Clin Nephrol; 1997 Jul; 48(1):29-33. PubMed ID: 9247775
[TBL] [Abstract][Full Text] [Related]
38. The case of the floating gel.
Srivastava R; Murphy MJ; Card J; Severn A; Fraser CG
J Clin Pathol; 2004 Dec; 57(12):1333-4. PubMed ID: 15563680
[TBL] [Abstract][Full Text] [Related]
39. Fluid balance, dry weight, and blood pressure in dialysis.
Charra B
Hemodial Int; 2007 Jan; 11(1):21-31. PubMed ID: 17257351
[TBL] [Abstract][Full Text] [Related]
40. Sequential sodium therapy allows correction of sodium-volume balance and reduces morbidity.
Murisasco A; France G; Leblond G; Durand C; el Mehdi M; Crevat A; Elsen R; Boobes Y; Baz M
Clin Nephrol; 1985 Oct; 24(4):201-8. PubMed ID: 4064378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
